It is also unclear why IMPDH inhibitors are particularly effective in MLL‐rearranged AML, despite the high expression of TLR1, TLR2, and TLR4 in some non‐MLL‐rearranged AMLs. This evidence concerns the gene KMT2A and acute myeloid leukemia.